Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Characterization of GPNMB/OA-induced breast cancer cell invasion and tumor metastasis
FY 2009-10
Summary
Breast cancer is the most commonly diagnosed cancer in Canadian women and the second leading cause of death in this group. With early detection and treatment, the 5-year survival rate of breast cancer is very hopeful, however, a dramatic decrease in survival rate is observed when breast cancer cells metastasize. Problems in therapeutic strategies developed to eliminate metastasis arise due to an incomplete understanding of the metastatic process. Our lab has identified a protein, GPNMB, which is highly expressed in breast cancer cells that aggressively metastasize to bone. We have shown that GPNMB increases the invasive properties of breast cancer cells, promotes the outgrowth of the primary tumor and drives the metastasis of breast cancer cells to the bone and lung. Additionally, we have shown that GPNMB decreases tumor cell death and increases vascular recruitment, which is necessary for cancer cells to maintain their growth and propagation. Clinical studies reveal that expression of GPNMB in breast cancer tumors is associated with poor prognosis and an increased recurrence rate for patients.
These findings reveal a pressing need for an understanding of GPNMB's mechanisms of action in order to identify potential anti-metastatic therapeutic targets. So far, we have shown that increases in GPNMB expression induce the upregulation of Neuropilin-1 and Clusterin. The established role of Neuropilin-1 in endothelial recruitment offers a precursory explanation for the observed GPNMB-induced increase in vascular content in tumor tissue. In addition, clusterin's confirmed role in cell death evasion is in line with the positive correlation of GPNMB/OA expression with primary tumor growth. Overall, the characterization of GPNMB's mechanisms of action is of critical importance in our search for therapeutic gateways that will inhibit the deadly spread of breast cancer cells.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
200358
Name
Maric Gordana
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Characterization of GPNMB/OA-induced breast cancer cell invasion and tumor metastasis
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Angiogenesis; Apoptosis; Breast Cancer; Clusterin; Gene Expression Profiling; Gpnmb/Osteoactivin; Lung); Metastasis (Bone; Motility/Invasion; Mouse Models; Neuropilin 1
Abstract
Breast cancer is the most commonly diagnosed cancer in Canadian women and the second leading cause of death in this group. With early detection and treatment, the 5-year survival rate of breast cancer is very hopeful, however, a dramatic decrease in survival rate is observed when breast cancer cells metastasize. Problems in therapeutic strategies developed to eliminate metastasis arise due to an incomplete understanding of the metastatic process. Our lab has identified a protein, GPNMB, which is highly expressed in breast cancer cells that aggressively metastasize to bone. We have shown that GPNMB increases the invasive properties of breast cancer cells, promotes the outgrowth of the primary tumor and drives the metastasis of breast cancer cells to the bone and lung. Additionally, we have shown that GPNMB decreases tumor cell death and increases vascular recruitment, which is necessary for cancer cells to maintain their growth and propagation. Clinical studies reveal that expression of GPNMB in breast cancer tumors is associated with poor prognosis and an increased recurrence rate for patients.
These findings reveal a pressing need for an understanding of GPNMB's mechanisms of action in order to identify potential anti-metastatic therapeutic targets. So far, we have shown that increases in GPNMB expression induce the upregulation of Neuropilin-1 and Clusterin. The established role of Neuropilin-1 in endothelial recruitment offers a precursory explanation for the observed GPNMB-induced increase in vascular content in tumor tissue. In addition, clusterin's confirmed role in cell death evasion is in line with the positive correlation of GPNMB/OA expression with primary tumor growth. Overall, the characterization of GPNMB's mechanisms of action is of critical importance in our search for therapeutic gateways that will inhibit the deadly spread of breast cancer cells.
Competitiondate
201002
Approvedterm2
1 yr 0 mth
Pinamesdelim
Maric, Gordana
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~